CSIR NET June 2017 Result

Important Notice Regarding CSIR-UGC NET June 2017 Result

2
Important Notice Regarding CSIR-UGC NET June 2017 Result Council of Scientific and Industrial Research Human Resource Development Group NOTICE Re: Joint CSIR-UGC JRF/NET EXAM held on 18th June...
Drug Firms Urge PMO to Intervene, Act against Gelatine Capsule Replacement

Drug Firms Urge PMO to Intervene, Act against Gelatine Capsule Replacement

0
Drug Firms Urge PMO to Intervene against Gelatine Capsule Replacement The Central Drugs Standard Control Organisation (CDSCO), under the Ministry of Health and Family Welfare,...
Tandon Researcher Developing Potential Antidotes to Neutralize Chemical Weapons

Tandon Researcher Developing Potential Antidotes to Neutralize Chemical Weapons

0
Researcher Developing Antidotes to Neutralize Chemical Weapons Among the Weapons of Mass Destruction (WMD), chemical warfare (CW) is probably one of the most brutal created...

Could Triple Protection Vaccine Spell the End of Pneumonia?

0
Could Triple Protection Vaccine Spell the End of Pneumonia? Although the number of pneumonia-related deaths reduced by one million between 2004 and 2015 due to...

New Strain of China’s Saltwater Rice Boosts Country’s Rice Harvest by Nearly 20%, Can...

0
China’s Saltwater Rice Boosts Country’s Rice Harvest by Nearly 20% Back in the 1970s, the godfather of rice, Yuan Longping was one of the first scientists...
Scientists Study the Third Type of Diabetes, Warn about Repercussions of Misdiagnosis

Scientists Study the Third Type of Diabetes, Warn about Repercussions of Misdiagnosis

0
Scientists Study the Third Type of Diabetes-Repercussions of Misdiagnosis Type 3c diabetes mellitus is more common than generally thought. Its prevalence is supposed to be...
Stanford's I-O Spinout Forty Seven Bags $75M in Series B Financing

Stanford’s I-O Spinout Forty Seven Bags $75M in Series B Financing

0
Stanford's I-O Spinout Forty Seven Bags $75M in Series B Financing I-O company, Forty Seven Inc., has now closed $75 million Series B financing, bringing in...
Turning on the Gene “Circuit” Switch to Combat Cancer

Turning on the Gene “Circuit” Switch to Combat Cancer

0
Turning on the Gene “Circuit” Switch to Combat Cancer Despite its success in several clinical trials, cancer immunotherapy remains limited by the rarity of targetable...
AstraZeneca Swiss Cancer Biotech Completes $200M Funding Round

AstraZeneca Backed Swiss Cancer Biotech Completes $200M Funding Round

0
AstraZeneca Swiss Cancer Biotech Completes $200M Funding Round Swiss cancer antibody-drug conjugate (ADC) developer ADC Therapeutics has now announced the close of its $200M mega...

IIT-M Rolls Out New Biotech Wing with State-of-Art Research Facilities

0
To note here is the first of its kind community-driven National Cancer Tissue Biobank, the animal house, and the Indo-German Sustainability Centre integrated into...
Netaji Subhas Fellowship, Young Scientist Fellowship, Novus Biologicals Scholarship, Jobs @ NBRC, NICED + Much More

Biotecnika Times – Newsletter 25.10.2017

0
IOC-DBT-Deakin Fellowships - Applications Invited Applications from Indian nationals for “IOC-DBT-Deakin Fellowships” to work in Biotechnology area are invited.............. Read More ISRO - SAC Hiring | JRF Post...
CDMO Pfizer CentreOne Announces Launch of New Facility in Japan

CDMO Pfizer CentreOne Announces Launch of New Facility in Japan

0
CDMO Pfizer CentreOne Announces Launch of New Facility in Japan Pfizer’s contract development and manufacturing organization are now all set to offer services in Nagoya,...
Scientists Validate a Biomarker Indicative of Glioblastoma Progression

Scientists Validate a Biomarker Indicative of Glioblastoma Progression, Drug Response

0
Scientists Validate a Biomarker Indicative of Glioblastoma Progression Glioblastoma is a highly aggressive and heterogeneous form of brain cancer, with a median survival time from...

Study Smokes out Gene That Turns Fungi into Pathogens

0
Study Smokes out Gene That Turns Fungi into Pathogens A new investigation by scientists at the Rothamsted Research illuminates how the fungus causes disease in...

Visterra Tops Off Series C Financing with $46.7M

0
Visterra Therapeutics Tops Off Series C Financing with $ 46.7M A clinical-stage biotechnology company, Visterra Therapeutics, has hauled a whopping $46.7 million in series C...